Sorafenib versus sunitinib as first-line treatment agents in Chinese patients with metastatic renal cell carcinoma: the largest multicenter retrospective analysis of survival and prognostic factors
2007 ◽
Vol 5
(4)
◽
pp. 301
◽
2008 ◽
Vol 7
(3)
◽
pp. 245
◽
Keyword(s):
2015 ◽
Vol 25
(5)
◽
pp. 395-401
◽
Keyword(s):
Keyword(s):
Keyword(s):